Related Experiment Video
Updated: Aug 15, 2026
06:16
Preparation Of Gushukang GSK Granules for In Vivo and In Vitro Experiments
Published on: May 9, 2019
7.6K
[Research progress in preparations of Panax ginseng]
Si-Yi Qin1, Jia-Min Lai2, Bin Jia3
1Guangdong Metabolic Diseases Research Center of Integrated Chinese and Western Medicine (Institute of Traditional Chinese Medicine), Guangdong Pharmaceutical University Guangzhou 510006, China NMPA Key Laboratory for Rapid Testing Technology of Drugs, Guangdong Institute for Drug Control Guangzhou 510663, China.
Summary
Panax ginseng, or Korean ginseng, is a revered herb with diverse health benefits. This review summarizes its clinical applications and market preparations, highlighting its potential for future medicinal development.
Area of Science:
- Pharmacology and Ethnobotany
- Traditional Chinese Medicine
- Phytochemistry
Background:
- Panax ginseng, the "king of herbs," is a highly valued medicinal plant, with roots being the most utilized part.
- Its primary active compounds include triterpenoid saponins, polysaccharides, peptides, and volatile oils.
- These components contribute to its wide range of pharmacological effects and healthcare applications.
Purpose of the Study:
- To systematically review the clinical application progress of Panax ginseng and its marketed preparations.
- To explore the future development prospects of Panax ginseng-derived preparations.
- To provide a reference for further research into the medicinal value and healthcare functions of Panax ginseng.
Main Methods:
- Literature review of clinical applications and marketed preparations of Panax ginseng.
- Analysis of the chemical constituents and pharmacological effects of Panax ginseng.
- Synthesis of information on traditional uses and modern clinical evidence.
Main Results:
- Panax ginseng preparations are widely marketed (tablets, oral liquids, injections) with proven efficacy.
- Key therapeutic areas include immune regulation, cancer adjuvant therapy, fatigue alleviation, anti-aging, metabolic improvement, cardiovascular health, and anti-inflammation.
- Production processes and quality standards are crucial for ensuring the efficacy of Panax ginseng drugs.
Conclusions:
- Panax ginseng possesses significant medicinal value and healthcare functions, supported by extensive clinical applications.
- Further development of Panax ginseng preparations holds promise for broader therapeutic applications.
- This review provides a foundation for in-depth exploration and utilization of Panax ginseng's medicinal potential.
More Related Videos
Related Concept Videos
01:26Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
01:23Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
01:01Dosage Regimens: Partial Pharmacokinetic Parameters
It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:24Pharmacokinetic–Pharmacodynamic Relationship: Problems
The empirical approach to drug therapy optimization relies on correlating pharmacological response with administered dosage. Such an approach can be costly, time-consuming, and often yields poor correlation due to variables like formulation factors and drug elimination characteristics. A more precise approach correlates response with plasma drug concentration or the amount of drug in the body, rather than dosage. This is achieved through pharmacokinetic-pharmacodynamic (PK/PD) modeling, which...
01:15Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).